KK
FOLD

KLP Kapitalforvaltning’s Amicus Therapeutics FOLD Stock Holding History

KLP Kapitalforvaltning’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,200
Closed -$843K – 2177
2025
Q4 		$843K Buy
59,200
+9,600
+19% +$94.3K ﹤0.01% 1122
2025
Q3 		$391K Hold
49,600
– – ﹤0.01% 1523
2025
Q2 		$284K Buy
49,600
+7,400
+18% +$47.8K ﹤0.01% 1622
2025
Q1 		$344K Sell
42,200
-6,800
-14% -$62.9K ﹤0.01% 1494
2024
Q4 		$462K Buy
+49,000
New +$509K ﹤0.01% 1426

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

KLP Kapitalforvaltning's FOLD Position: Q1 2026 in Review

KLP Kapitalforvaltning sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 59,200 shares — an estimated $843K sold.

KLP Kapitalforvaltning first reported a position in FOLD in Q4 2024 and held it in 5 quarters. The position peaked at $843K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • KLP Kapitalforvaltning reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 59,200 Amicus Therapeutics shares in Q1 2026, an estimated $843K.
  • KLP Kapitalforvaltning first reported a position in Amicus Therapeutics in Q4 2024 and held it in 5 quarters.
  • KLP Kapitalforvaltning's Amicus Therapeutics position peaked at $843K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.